Abstract
Due to an oversight, one of the author’s name was published wrong in the article entitled “A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation” in “Anti-Cancer Agents in Medicinal Chemistry, 2015, Vol. 15, No. 4, pp. 517.”
The correct names of all authors are given below: Samar Said Fatahala*, Emad Ahmed Shalaby, Shaymaa Emam Kassab and Mossad Said Mohamed to Mossad Sayed Mohamed
Anti-Cancer Agents in Medicinal Chemistry
Title:CORRIGENDUM A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation
Volume: 18 Issue: 10
Author(s):
Affiliation:
Abstract: Due to an oversight, one of the author’s name was published wrong in the article entitled “A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation” in “Anti-Cancer Agents in Medicinal Chemistry, 2015, Vol. 15, No. 4, pp. 517.”
The correct names of all authors are given below: Samar Said Fatahala*, Emad Ahmed Shalaby, Shaymaa Emam Kassab and Mossad Said Mohamed to Mossad Sayed Mohamed
Export Options
About this article
Cite this article as:
, CORRIGENDUM A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (10) . https://dx.doi.org/10.2174/187152061810181211124824
DOI https://dx.doi.org/10.2174/187152061810181211124824 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Challenges and Opportunities in Molecular Imaging
Current Medical Imaging From Presenilinase to γ-Secretase, Cleave to Capacitate
Current Alzheimer Research Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets The Ubiquitin Proteasome System as a Potential Target for the Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design Cot/Tpl-2 Protein Kinase as a Target for the Treatment of Inflammatory Disease
Current Topics in Medicinal Chemistry Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer
Current Medicinal Chemistry Innovation in Contrast Agents for Magnetic Resonance Imaging
Current Medical Imaging Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Towards Breast Cancer Vaccines, Progress and Challenges
Current Drug Discovery Technologies Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Developments Towards a Prophylactic Hepatitis C Virus Vaccine
Current Immunology Reviews (Discontinued) Elicitation of Immune Responsiveness Against Antigenic Challenge in Age- Related Diseases: Effects of Red Wine Polyphenols
Current Pharmaceutical Design Is There a Role for Antioxidants in the Prevention of Infection-Associated Carcinogenesis and in the Treatment of Infection-Driven Tumors?
Current Topics in Medicinal Chemistry Plasminogen Activator System and Vascular Disease
Current Vascular Pharmacology Bioactivity of Turmeric-derived Curcuminoids and Related Metabolites in Breast Cancer
Current Pharmaceutical Design Regulation of Expression and Function of IDO in Human Dendritic Cells
Current Medicinal Chemistry Role of NF-κB in the Regulation of Cytochrome P450 Enzymes
Current Drug Metabolism Inhibitors for Metastasis Development
Recent Patents on Anti-Cancer Drug Discovery Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target
Current Cancer Therapy Reviews Discovery of Novel Plant Peptides as Strong Inhibitors of Metalloproteinases
Protein & Peptide Letters